Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.44 |
| ▸ | NPY1R | P25929 | 6/20 | 0.44 |
| ▸ | NPY2R | P49146 | 4/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.44 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | FNTA | P49354 | 1/20 | 0.38 |
| ▸ | FNTB | P49356 | 1/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30249102 | 1.00 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL268800 | 1.00 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL269045 | 1.00 | NPY4R (0.44) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30081096 | 0.97 | NPY4R (0.47) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL29779797 | 0.96 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL29887603 | 0.96 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL18660499 | 0.96 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30121059 | 0.96 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL30120978 | 0.96 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5RNOD1 | |
| SCHEMBL3753495 | 0.95 | NOD1 (0.46) | NPY4RNPY1RNPY2RNPY5RNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2538803-B1 | FORMULATIONS AND METHODS FOR NUTRIENT DELIVERY | MJN US HOLDINGS LLC (US) | 2017-03-29 | — | — | EP | claimed |
| US-9327001-B2 | Nutritional supplement for weight management | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2016-05-03 | — | — | US | claimed |
| WO-2014176222-A1 | NUTRITIONAL SUPPLEMENT FOR WEIGHT MANAGEMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2014-10-30 | — | — | WO | claimed |
| US-20140286923-A1 | NUTRITIONAL SUPPLEMENT FOR WEIGHT MANAGEMENT | UNIVERSITY OF FLORIDA RESEACH FOUNDATION, INC. (US) | 2014-09-25 | — | — | US | claimed |
| EP-2773363-A1 | NUTRITIONAL SUPPLEMENT FOR WEIGHT MANAGEMENT | University of Florida Research Foundation, Inc. (US) | 2014-09-10 | — | — | EP | claimed |
| WO-2013067485-A1 | NUTRITIONAL SUPPLEMENT FOR WEIGHT MANAGEMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-05-10 | — | — | WO | claimed |
| EP-2538803-A1 | FORMULATIONS AND METHODS FOR NUTRIENT DELIVERY | Mead Johnson Nutrition Company (US) | 2013-01-02 | — | — | EP | claimed |
| CN-102762115-A | Nutrient delivery formulation and method | MEAD JOHNSON NUTRITION CO | 2012-10-31 | — | — | CN | claimed |
| US-8133868-B2 | Dipeptides for prevention of muscle breakdown and microbial infection | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2012-03-13 | — | — | US | claimed |
| WO-2011106482-A1 | FORMULATIONS AND METHODS FOR NUTRIENT DELIVERY | MEAD JOHNSON NUTRITION COMPANY (US) | 2011-09-01 | — | — | WO | claimed |
| US-20090082283-A1 | Dipeptides for Prevention of Muscle Breakdown and Microbial Infection | NEU JOSEF | 2009-03-26 | — | — | US | claimed |
| US-20070054866-A1 | Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation | NEU JOSEF | 2007-03-08 | — | — | US | claimed |
| US-7148199-B2 | Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2006-12-12 | — | — | US | claimed |
| US-20060229256-A1 | Enternal administration of arginine and glutamine for abnormal vascular proliferation | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-10-12 | — | — | US | claimed |
| US-20050089547-A1 | Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation | BRISTOL-MYERS SQUIBB COMPANY | 2005-04-28 | — | — | US | claimed |
| WO-2005030242-A1 | ARGINYL-GLUTAMINE DIPEPTIDE FOR TREATMENT OF PATHOLOGICAL VASCULAR PROLIFERATION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC (US) | 2005-04-07 | — | — | WO | claimed |
| WO-2005030243-A1 | ARGINYL-GLUTAMINE DIPEPTIDE FOR TREATMENT OF PATHOLOGICAL VASCULAR PROLIFERATION | BRISTOL MYERS SQUIBB COMPANY (US) | 2005-04-07 | — | — | WO | claimed |
| US-20050070484-A1 | Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2005-03-31 | — | — | US | claimed |
| US-20040097426-A1 | Dipeptides for prevention of muscle breakdown and microbial infection | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2004-05-20 | — | — | US | claimed |
| WO-2003017787-A1 | DIPEPTIDES FOR PREVENTION OF MUSCLE BREAKDOWN AND MICROBIAL INFECTION | UNIVERSITY OF FLORIDA (US) | 2003-03-06 | — | — | WO | claimed |